Penn in the News

According to a Perelman School of Medicine study, women taking popular GLP-1 weight-loss drugs had a 30% less risk of developing breast cancer.

Shaun Ossei-Owusu of Penn Carey Law School’s “Law on Trial” is reviewed.

Mohamed El-Erian of the Wharton School discusses the future of the Federal Reserve, the latest market trends, the state of the economy, the impact of AI, and more.

Ravi Amaravadi of the Perelman School of Medicine comments on research on a new vaccine that shows promise in keeping deadly skin cancer from returning for years.

PIK Professor Michael Platt and the Wharton Neuroscience Initiative are featured in a documentary special exploring the link between friendship and overall health

Vasowatch, a technology company that monitors a heart rate during labor to prevent postpartum bleeding, started at the Penn Center for Innovation.

CCP grad Daniel "Danny" Emdin will attend the Penn in the fall with the help of a prestigious scholarship that will cover up to $55,000 annually.

Dennis Culhane of the School of Social Policy & Practice comments on a recent homelessness report.

Danny Cullenward of the Kleinman Center for Energy Policy at the Weitzman School of Design says California’s new incentive program for manufacturers and refiners is untested and lacks sufficient guardrails to prevent abuse.

Susan C. Taylor of the Perelman School of Medicine says, “When UV is high, it means there are many UV rays getting through, so you need to double your skin protection efforts, avoiding the sun between the peak hours of 10 a.m. and 2 p.m. and wearing hats, sunglasses, rash guards.”